131 related articles for article (PubMed ID: 33770374)
1. Revisiting detection of in-transit metastases in melanoma patients using digital
Zimmermann PA; Houdu B; Césaire L; Nakouri I; De Pontville M; Lasnon C; Aide N
Ann Nucl Med; 2021 Jun; 35(6):669-679. PubMed ID: 33770374
[TBL] [Abstract][Full Text] [Related]
2. Why harmonization is needed when using FDG PET/CT as a prognosticator: demonstration with EARL-compliant SUV as an independent prognostic factor in lung cancer.
Houdu B; Lasnon C; Licaj I; Thomas G; Do P; Guizard AV; Desmonts C; Aide N
Eur J Nucl Med Mol Imaging; 2019 Feb; 46(2):421-428. PubMed ID: 30218317
[TBL] [Abstract][Full Text] [Related]
3. Image Quality and Activity Optimization in Oncologic
van Sluis J; Boellaard R; Dierckx RAJO; Stormezand GN; Glaudemans AWJM; Noordzij W
J Nucl Med; 2020 May; 61(5):764-771. PubMed ID: 31628214
[TBL] [Abstract][Full Text] [Related]
4.
Lasnon C; Majdoub M; Lavigne B; Do P; Madelaine J; Visvikis D; Hatt M; Aide N
Eur J Nucl Med Mol Imaging; 2016 Dec; 43(13):2324-2335. PubMed ID: 27325312
[TBL] [Abstract][Full Text] [Related]
5. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
6. Generating harmonized SUV within the EANM EARL accreditation program: software approach versus EARL-compliant reconstruction.
Lasnon C; Salomon T; Desmonts C; Dô P; Oulkhouir Y; Madelaine J; Aide N
Ann Nucl Med; 2017 Feb; 31(2):125-134. PubMed ID: 27812791
[TBL] [Abstract][Full Text] [Related]
7. Repeatability of
Pfaehler E; Beukinga RJ; de Jong JR; Slart RHJA; Slump CH; Dierckx RAJO; Boellaard R
Med Phys; 2019 Feb; 46(2):665-678. PubMed ID: 30506687
[TBL] [Abstract][Full Text] [Related]
8. Improving the detection of small lesions using a state-of-the-art time-of-flight PET/CT system and small-voxel reconstructions.
Koopman D; van Dalen JA; Lagerweij MC; Arkies H; de Boer J; Oostdijk AH; Slump CH; Jager PL
J Nucl Med Technol; 2015 Mar; 43(1):21-7. PubMed ID: 25613334
[TBL] [Abstract][Full Text] [Related]
9. The value of Bayesian penalized likelihood reconstruction for improving lesion conspicuity of malignant lung tumors on
Kurita Y; Ichikawa Y; Nakanishi T; Tomita Y; Hasegawa D; Murashima S; Hirano T; Sakuma H
Ann Nucl Med; 2020 Apr; 34(4):272-279. PubMed ID: 32060780
[TBL] [Abstract][Full Text] [Related]
10. Improved detection of in-transit metastases of malignant melanoma with BSREM reconstruction in digital [
Liberini V; Messerli M; Husmann L; Kudura K; Grünig H; Maurer A; Skawran S; Orita E; Pizzuto DA; Deandreis D; Dummer R; Mangana J; Mihic-Probst D; Rupp N; Huellner MW
Eur Radiol; 2021 Oct; 31(10):8011-8020. PubMed ID: 33768288
[TBL] [Abstract][Full Text] [Related]
11. EARL compliance and imaging optimisation on the Biograph Vision Quadra PET/CT using phantom and clinical data.
van Sluis J; van Snick JH; Brouwers AH; Noordzij W; Dierckx RAJO; Borra RJH; Slart RHJA; Lammertsma AA; Glaudemans AWJM; Boellaard R; Tsoumpas C
Eur J Nucl Med Mol Imaging; 2022 Nov; 49(13):4652-4660. PubMed ID: 35876867
[TBL] [Abstract][Full Text] [Related]
12. Digital PET compliance to EARL accreditation specifications.
Koopman D; Groot Koerkamp M; Jager PL; Arkies H; Knollema S; Slump CH; Sanches PG; van Dalen JA
EJNMMI Phys; 2017 Dec; 4(1):9. PubMed ID: 28144857
[TBL] [Abstract][Full Text] [Related]
13. Phantom-based acquisition time and image reconstruction parameter optimisation for oncologic FDG PET/CT examinations using a digital system.
Fragoso Costa P; Jentzen W; Brahmer A; Mavroeidi IA; Zarrad F; Umutlu L; Fendler WP; Rischpler C; Herrmann K; Conti M; Seifert R; Sraieb M; Weber M; Kersting D
BMC Cancer; 2022 Aug; 22(1):899. PubMed ID: 35978274
[TBL] [Abstract][Full Text] [Related]
14. Protocols for Harmonized Quantification and Noise Reduction in Low-Dose Oncologic
Machado MAD; Menezes VO; Namías M; Vieira NS; Queiroz CC; Matheoud R; Alessio AM; Oliveira ML
J Nucl Med Technol; 2019 Mar; 47(1):47-54. PubMed ID: 30076252
[TBL] [Abstract][Full Text] [Related]
15. Experimental Multicenter and Multivendor Evaluation of the Performance of PET Radiomic Features Using 3-Dimensionally Printed Phantom Inserts.
Pfaehler E; van Sluis J; Merema BBJ; van Ooijen P; Berendsen RCM; van Velden FHP; Boellaard R
J Nucl Med; 2020 Mar; 61(3):469-476. PubMed ID: 31420497
[TBL] [Abstract][Full Text] [Related]
16. Image Quality and Semiquantitative Measurements on the Biograph Vision PET/CT System: Initial Experiences and Comparison with the Biograph mCT.
van Sluis J; Boellaard R; Somasundaram A; van Snick PH; Borra RJH; Dierckx RAJO; Stormezand GN; Glaudemans AWJM; Noordzij W
J Nucl Med; 2020 Jan; 61(1):129-135. PubMed ID: 31253742
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic performance of
Hotta M; Minamimoto R; Yano H; Gohda Y; Shuno Y
Cancer Imaging; 2018 Jan; 18(1):4. PubMed ID: 29378659
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of Penalized-Likelihood Estimation Reconstruction on a Digital Time-of-Flight PET/CT Scanner for
Lindström E; Sundin A; Trampal C; Lindsjö L; Ilan E; Danfors T; Antoni G; Sörensen J; Lubberink M
J Nucl Med; 2018 Jul; 59(7):1152-1158. PubMed ID: 29449445
[TBL] [Abstract][Full Text] [Related]
19. Repeatability of [
Kolinger GD; Vállez García D; Kramer GM; Frings V; Smit EF; de Langen AJ; Dierckx RAJO; Hoekstra OS; Boellaard R
EJNMMI Res; 2019 Feb; 9(1):14. PubMed ID: 30734113
[TBL] [Abstract][Full Text] [Related]
20. Harmonizing FDG PET quantification while maintaining optimal lesion detection: prospective multicentre validation in 517 oncology patients.
Quak E; Le Roux PY; Hofman MS; Robin P; Bourhis D; Callahan J; Binns D; Desmonts C; Salaun PY; Hicks RJ; Aide N
Eur J Nucl Med Mol Imaging; 2015 Dec; 42(13):2072-82. PubMed ID: 26219870
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
